Results 171 to 180 of about 39,263 (231)

Weight-Loss and Metformin-Use Improve the Reversal Rate in Patients with Endometrial Hyperplasia. [PDF]

open access: yesInt J Womens Health
Kuai D   +10 more
europepmc   +1 more source

Endometrial Hyperplasia

Obstetrics & Gynecology, 2022
The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the etiology and risk factors, histologic classification and subtypes, malignant progression risks, prevention options, and to outline both surgical and nonsurgical treatment options.
Kari L, Ring   +2 more
openaire   +2 more sources

Endometrial hyperplasia

Seminars in Diagnostic Pathology, 2010
Endometrial hyperplasia is a heterogeneous set of pathologic lesions that range from mild, reversible glandular proliferations to direct cancer precursors. These lesions comprise a continuum of morphologic appearances, with the earliest proliferation represented by crowded glands with simple tubular architecture lined by cells resembling proliferative ...
Anne M, Mills, Teri A, Longacre
openaire   +2 more sources

Endometrial hyperplasia

The Obstetrician & Gynaecologist, 2008
The most common presenting symptom of endometrial hyperplasia is abnormal uterine bleeding. In the UK, hysteroscopy remains the gold standard of investigations for abnormal uterine bleeding. The clinical importance of endometrial hyperplasia largely relates to the risk of progression to endometrial carcinoma. Progestin therapy is appropriate for most
Julia E Palmer   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy